Trial | NCT01055470  Report issue

Title

Comparative Clinical Trial of Lornoxicam to Diclofenac in Patients of Osteoarthritis of Knee Joint.
Open, Randomized, Controlled Clinical Trial of Lornoxicam as Compared to Diclofenac in Osteoarthritis of Knee Joint in Patients of Tertiary Care Hospital of Gujarat.

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    40
The purpose of this study was to compare the pain relieving action of the lornoxicam and diclofenac in patients of OA knee.
Study Started
Dec 31
2008
Primary Completion
Jun 30
2009
Study Completion
Jun 30
2009
Last Update
Jan 25
2010
Estimate

Drug Diclofenac

Tab. Diclofenac 50 mg 12 hrly, orally, in morning and in evening after taking food for 3 months.

Drug Lornoxicam

Tab. Lornoxicam 4 mg , orally, 8 hourly after taking food in morning , in noon and evening for 3 months.

Diclofenac Active Comparator

Tab.Diclofenac 50 mg ,Orally, 12 hrly in morning and in evening after taking food for 3 months.

Lornoxicam Experimental

Tab. Lornoxicam 4 mg , orally, 8 hourly after taking food in morning , in noon and evening for 3 months.

Criteria 

Inclusion Criteria:

Newly diagnosed patient aged between 25 to 65 yrs of either gender suffering from osteoarthritis of knee according to criteria given by American College of Rheumatology
Informed consent obtained from the patient.

Exclusion Criteria:

Patients with any other systemic llness,
Patients with pregnancy and lactation,
Patients taking other drugs like lithium[4], digoxin, methotrexate, anticoagulants, antidiabetics, diuretics,
Patients with H/O hypersensitivity to NSAIDs,
Patients who had consumed any analgesics in last 1 month
No Results Posted